Search for a research project
Other search option(s)
235 Result(s)
Terminated research projects = 
Funded by an IRDiRC member = 
Member of a ERN = 
Research projects
BELGIUM
VLAAMS BRABANT
LEUVEN
HDACALS: Investigating the therapeutic potential of inhibition of histone deacetylases in a FUS mouse model of ALS
UZ Leuven - Campus Gasthuisberg
Ludo Van Den Bosch Lab- VIB-KU Leuven Center for Brain & Disease Research
CANADA
Alberta
EDMONTON
MRI biomarkers in ALS
University of Alberta
Department of Medicine, Division of Neurology
CANADA
Alberta
EDMONTON
Promoting protection of functionally intact motor units in amyotrophic lateral sclerosis (ALS).
University of Alberta
Faculty of Physical Education and Recreation
CANADA
Colombie-Britannique
VANCOUVER
Computation and theory to predict structures and mechanisms for protein misfolding in amyotrophic lateral sclerosis
University of British Columbia
Department of Physics and Astronomy
CANADA
Ontario
OTTAWA
Loss of VAPB Function in Amyotrophic Lateral Sclerosis-8 (ALS8)
Ottawa Hospital Research Institute
Neuroscience
CANADA
Ontario
TORONTO
The TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis
University of Toronto
Centre for Research in Neurodegenerative Disease
CANADA
Ontario
WATERLOO
Folding and aggregation of ALS-associated mutant superoxide dismutases
University of Waterloo
Department of Chemistry
CANADA
Québec
ADDRESS: NOT PROVIDED - CA
Inhibiting C9ORF72 Repeat RNA Transcription with a Common Class of Small Molecules - CA
Institution: Information not provided - CA
CANADA
Québec
MONTRÉAL
Understanding G3BP1 and stress granule dynamics in ALS pathogenesis
Centre Hospitalier de l'Université de Montréal
Département de biochimie et médecine moléculaire
CANADA
Québec
MONTRÉAL
Regeneration of motor neurons controlling movement and respiration from embryonic stem cells
Montreal Neurological Institute and Hospital
McGill University
CANADA
Québec
MONTRÉAL
Regulation of motor neuron identity and circuit development
Montreal Neurological Institute and Hospital
McGill University
CANADA
Québec
MONTRÉAL
Targeting glial cells to restore neuromuscular function and improve motor outcome in ALS
Université de Montréal
Département de neurosciences
FINLAND
Finland
HELSINKI
CDNF and CDNF variants- novel therapy for ALS
Biocenter 1, University of Helsinki
Institute of Biotechnology
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Generating novel tools to investigate the in vivo role of miR-124 in motor neurone physiology and ALS pathogenesis
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Modulation expérimentale de la flexibilité métabolique dans la sclérose latérale amyotrophique comme nouvelle approche thérapeutique.
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Synaptic Inputs from and to Vulnerable and Resistant Motoneurons in Amyotrophic Lateral Sclerosis
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Unravelling the role of upper motor neurons in Amyotrophic lateral sclerosis onset and progression
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Role of the calcium-activated chloride channel TMEM16F in amyotrophic lateral sclerosis
Institution: Information not provided - FR
FRANCE
BOURGOGNE-FRANCHE-COMTE
DIJON
Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral Sclerosis
HOPITAL LE BOCAGE CHRU DIJON
Pneumologie
FRANCE
GRAND-EST
ILLKIRCH-GRAFFENSTADEN
C9ORF72-ALS: Role of C9ORF72 in Amyotrophic Lateral Sclerosis
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique
FRANCE
GRAND-EST
ILLKIRCH-GRAFFENSTADEN
Study of new mutations in the C9ORF72 gene responsible for Amyotrophic Lateral Sclerosis
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique
FRANCE
GRAND-EST
STRASBOURG
Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
Faculté de médecine de Strasbourg - Louis Pasteur
Laboratoire de signalisations moléculaires et neurodégénérescence
FRANCE
GRAND-EST
STRASBOURG
Modulation of metabolic flexibility in Amyotrophic Lateral Sclerosis as a new therapeutic approach - FR
Faculté de médecine de Strasbourg - Louis Pasteur
Laboratoire de signalisations moléculaires et neurodégénérescence
FRANCE
GRAND-EST
STRASBOURG
Role of CA-repeating microsatellites in FUS and TDP-43 related diseases
Faculté de médecine de Strasbourg - Louis Pasteur
Mécanismes centraux et périphériques de la Neurodégénérescence - INSERM U1118
FRANCE
GRAND-EST
STRASBOURG
Muscle contribution to FUS-associated ALS: genetic and mechanistic insights - FR
Faculté de médecine de Strasbourg - Louis Pasteur
Mécanismes centraux et périphériques de la Neurodégénérescence - INSERM U1118
FRANCE
GRAND-EST
STRASBOURG
Deciphering the mechanisms of repeat-associated non-AUG (RAN) translation in amyotrophic lateral sclerosis
IBMC - Institut de biologie moléculaire et cellulaire
Evolution des Systèmes d'Initiation de la Traduction chez les eucaryotes
FRANCE
GRAND-EST
STRASBOURG
MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - FR
Institut Pluridisciplinaire Hubert Curien
Spectrométrie de masse bio organique
FRANCE
HAUTS-DE-FRANCE
LILLE
Assessment of the ethical and legal issues of the use of telemedicine in the support of patients with advanced stage Amyotrophic lateral sclerosis
GH de l'Institut Catholique de Lille - Hopital Saint Vincent de Paul
Institut catholique de Lille - ICL ETHICS EA 7446
FRANCE
ILE-DE-FRANCE
PARIS
Cell signaling, Reinnervation and Metabolism in Amyotrophic Lateral Sclerosis (CERMALS)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Unité Nerf périphérique, Sclérose Latérale Amyotrophique (SLA)
FRANCE
ILE-DE-FRANCE
PARIS
Efficacy, activity and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
FRANCE
ILE-DE-FRANCE
PARIS
Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Département de Neurologie - Pôle des Maladies du Système Nerveux
FRANCE
ILE-DE-FRANCE
PARIS
Defining functional networks of genetic causes for ALS and related neurodegenerative disorders
Inserm-ANRS
Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)
FRANCE
ILE-DE-FRANCE
PARIS
Using PML nuclear body biology to identify potential AML treatment targets
Inserm-ANRS
Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)
FRANCE
ILE-DE-FRANCE
PARIS
Development of an innovative therapeutic molecule for the treatment of a rare disease: Amyotrophic Lateral Sclerosis
Institut Pasteur
FRANCE
ILE-DE-FRANCE
PARIS
New gene therapy approaches for familial forms of amyotrophic lateral sclerosis
Institut de Myologie - Hôpital Pitié-Salpêtrière
Centre de Recherche en Myologie
FRANCE
ILE-DE-FRANCE
PARIS
AAV-mediated delivery of FGF as a therapeutic strategy for Amyotrophic Lateral Sclerosis
Institut de Myologie - Hôpital Pitié-Salpêtrière
Centre de Recherche en Myologie
FRANCE
ILE-DE-FRANCE
PARIS
Study of the interactions between microglial cells, macrophages and neurons from three axes in an animal model of amyotrophic lateral sclerosis
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"
FRANCE
ILE-DE-FRANCE
PARIS
Deciphering respective contributions of macrophages and microglia to motor neuron degeneration in Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis with microfluidic devices
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Causes de la SLA et mécanismes de la dégénérescence motoneuronale"
FRANCE
ILE-DE-FRANCE
PARIS
Localisation and identification of causative genes for amyotrohic lateral sclerosis
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Excitabilité, synapse & pathologies associées"
FRANCE
ILE-DE-FRANCE
PARIS
Amyotrophic Lateral Sclerosis gene therapy by restoring neuronal cholesterol metabolism
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Institut du Cerveau et de la Moëlle épinière - INSERM U1127
FRANCE
ILE-DE-FRANCE
PARIS CEDEX 06
The effect of autophagy induction on the neuromuscular junction in ALS
Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119
Développement et pathologies des jonctions neuromusculaires
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
Chloride-related inhibition in spinal motoneurons during the ALS disease progression in mouse model
Université Bordeaux 2 - Victor Ségalen
Institut de Neurosciences Cognitives et Intégratives - CNRS UMR 5287
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
The P2X4 receptor: a key player in Amyotrophic Lateral Sclerosis and a biomarker
Université Bordeaux 2 - Victor Ségalen
Institut des Maladies Neurodégénératives (IMN) - CNRS UMR 5293
FRANCE
OCCITANIE
MONTPELLIER
Spread and Toxicity of Pathogenic Factors in Amyotrophic Lateral Sclerosis
CHU de Montpellier - Hôpital Saint-Eloi
Institut des Neurosciences de Montpellier - INSERM U1051
FRANCE
OCCITANIE
MONTPELLIER
AAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis - FR
CHU de Montpellier - Hôpital Saint-Eloi
Institut des Neurosciences de Montpellier - INSERM U1051
FRANCE
OCCITANIE
MONTPELLIER
Insights into the mode of action of flunarizine on microRNAs and/or targets in rare motor neurondiseases
Centre de recherche Inserm
Degeneration and plasticity of the locomotor system
FRANCE
OCCITANIE
MONTPELLIER
Determine how local translation of mRNA impacts neurodegenerative diseases
UMR5535 Institut de génétique moléculaire de Montpellier (IGMM)
Assemblage et Trafic de Ribonucléoprotéines
FRANCE
OCCITANIE
MONTPELLIER CEDEX 05
Deciphering the beneficial effects of Sigma-1 receptor in amyotrophic lateral sclerosis
Mécanismes moléculaires dans les démences neurodégénératives (MMDN)
MMDN - Mécanismes Moléculaires dans les Démences Neurodégénératives
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
REPETOMICS: Genomic Instability of Expanded Repeats in HD and ALS/FTD - FR
Institut de Neurosciences de la Timone
UMR7289
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
G4C2 Repeat Sizing by Bionano Optical Mapping
Université de médecine Aix-Marseille Université
Institut des Neurosciences de la Timone
FRANCE
PROVENCE-ALPES-COTE D'AZUR
NICE
In vivo and in vitro direct lineage reprogramming of neuronal and somatic cells to corticospinal motor neurons
Université de Nice Sophia-Antipolis - Faculté des sciences
iBV - Institut de Biologie Valrose
GERMANY
Baden-Württemberg
TÜBINGEN
INTEGRALS: INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis -DE
DZNE-Standort Tübingen
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V.
GERMANY
Baden-Württemberg
ULM
REPETOMICS: Genomic Instability of Expanded Repeats in HD and ALS/FTD -DE
Universitäts- und Rehabilitationskliniken Ulm (RKU)
Klinik für Neurologie
GERMANY
Bayern
MARTINSRIED/PLANEGG
MAIV: Interdisciplinary consortium for the establishment of an in vitro disease model of ASL
BioMedical Center - BMC
Department of Physiological Genomics
GERMANY
Bayern
MÜNCHEN
MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - coordination, biomaterials and biomarkers -DE
Klinikum rechts der Isar der Technischen Universität München
Neurologische Klinik und Poliklinik
GERMANY
Berlin
BERLIN
Id-ALS-Study: Identification of genetic variants in ALS
Charité - Universitätsmedizin Berlin (CVK)
Klinik für Neurologie mit Experimenteller Neurologie (CVK)
GERMANY
Hamburg
HAMBURG
MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - coordination, biomaterials and biomarkers -DE
Zentrum für molekulare Neurobiologie Hamburg
GERMANY
Nordrhein-Westfalen
BONN
INTEGRALS: INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis -DE
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
GERMANY
Nordrhein-Westfalen
BONN
MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - coordination, biomaterials and biomarkers -DE
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany
GERMANY
Nordrhein-Westfalen
ESSEN
DigiNOA: A Study to Assess the Clinical Validity of Konectom in Adults Living With Neuromuscular Disorders
Universitätsklinikum Essen
Klinik für Neurologie
GERMANY
Sachsen
DRESDEN
Deficits and potential for improvement in the psychosocial and palliative care of ALS patients in Germany
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Klinik und Poliklinik für Neurologie
GERMANY
Schleswig-Holstein
LÜBECK
Uncovering novel causes and modifiers of amyotrophic lateral sclerosis by nuclear and mitochondrial genome sequencing
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Neurologie
IRELAND
County Dublin
DUBLIN
EEG and TMS-based Biomarkers of ALS, MS and FTD
Trinity College Dublin
Department of Neurology - Trinity Biomedical Sciences Institute
IRELAND
County Dublin
DUBLIN
Detecting the dark matter of neurodegeneration: repeat expansions in amyotrphic lateral sclerosis
Trinity College Dublin
Smurfit Institute of Genetics
ISRAEL
ISRAEL
REHOVOT
Rigorous, integrated miRNA-DNA plasma biomarkers for amyotrophic lateral sclerosis
Arnold R. Meyer Institute of Biological Sciences, Weizmann Institute of Science
Department of Molecular Genetics
ISRAEL
ISRAEL
TEL AVIV
ALS-degeneration: The molecular basis for neurodegeneration and muscle atrophy in ALS - IL
University of Tel-Aviv
Dept. of Physiology and Pharmacology
ISRAEL
ISRAEL
TEL AVIV-YAFO
An Prospective Study in a Cohort of Amyotrophic Lateral Sclerosis (ALS) Patients Participating in a Phase IIb Drug Study (NCT05357950) to Evaluate the Correlation Between Oculometric Measurements and ALS Functional Rating Scale (ALSFRS-R)
Sackler Faculty of Medicine
Department of Neurology
ITALY
LAZIO
ROMA
Proposal for an integrated approach to rare diseases: a study between basic laboratory models and clinical epidemiology in amyotrophic lateral sclerosis (ALS)
ISS - Istituto Superiore di Sanità
Reparto Farmaci per la Salute del Bambino e della Donna - Dipartimento del Farmaco
ITALY
LAZIO
ROMA
Amyotrophic Lateral Sclerosis (ALS) Registry in Latium Region
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Prevenzione delle Malattie e la Promozione della Salute
ITALY
LAZIO
ROMA
Exosomal RNA for the diagnosis of ALS
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
ITALY
LAZIO
ROMA
Following drug repurposing strategy: Preclinical assessment of new potential therapeutic target/drug in the SOD1G93A mouse model
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
ITALY
LAZIO
ROMA
Uncovering the function of HDAC4 in skeletal muscle
Sapienza Università di Roma - Sezione di Ricerca "Valdoni Lab"
Dipartimento di Scienze Anatomiche, Istologiche, Medico Legali e dell'Apparato Locomotore
ITALY
LOMBARDIA
MILANO
Modulating motor neuron vulnerability using the oculomotor restricted genes IGF-2 and SYT13 for ALS therapy
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Dipartimento di Scienze Neurologiche
ITALY
LOMBARDIA
MILANO
Salivary Raman Fingerprint as Biomarker for the Diagnosis of Amyotrophic Lateral Sclerosis
IRCCS S. Maria Nascente
ITALY
LOMBARDIA
MILANO
Preclinical studies aimed to develop target genes based therapies for the treatment of amyotrophic lateral sclerosis
Istituto di Ricerche Farmacologiche "Mario Negri"
Laboratorio di Neurobiologia Molecolare
ITALY
LOMBARDIA
PAVIA
Apoptosis of spinal cord astrocytes secondary to ALS-Linked SOD1 mutations: mechanism, relevance for motor neuron degeneration and protective pharmacological intervention.
Istituti Clinici Scientifici Maugeri IRCCS
Laboratorio di Ricerca sulle malattie Neurodegenerative
ITALY
LOMBARDIA
PAVIA
Novel therapeutic strategies for Spinal Muscular Atrophy: testing the efficacy of cell-permeable peptides in preclinical models
Istituti Clinici Scientifici Maugeri IRCCS
Laboratorio di Ricerca sulle malattie Neurodegenerative
ITALY
PIEMONTE
TORINO
Mutations in the MATR3 gene as a cause of amyotrophic lateral sclerosis (ALS)
Ospedale Molinette
Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica e le malattie del motoneurone
ITALY
PIEMONTE
TORINO
The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis
Università degli Studi di Torino
ITALY
PUGLIA
BARI
Amyotrophic lateral sclerosis (SLA) and riboflavin responsive multiple Acyl-CoA dehydrogenase deficiency (RR-MADD)
Università degli Studi di Bari Aldo Moro
Laboratorio di Biochimica e Biologia Molecolare E.Quagliarello
NETHERLANDS
Gelderland
NIJMEGEN
Muscle contribution to FUS-associated ALS: genetic and mechanistic insights - NL
Donders Centre for Cognition
PORTUGAL
SUL
LISBOA
Crosstalk between neurotrophic factor receptors (TrkB) and adenosine A2A receptors: implications for Amyotrophic Lateral Sclerosis (ALS).
Faculdade de Medicina da Universidade de Lisboa
Unidade de Neurociências
PORTUGAL
SUL
LISBOA
Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact.
Faculdade de Medicina da Universidade de Lisboa
Unidade de Neuromusculares
PORTUGAL
SUL
OEIRAS
Mechanisms of SOD1 toxic aggregation in neurodegenerative processes
Instituto de Tecnologia Química e Biológica
Protein Biochemistry Folding and Stability
SPAIN
Aragón
ZARAGOZA
Epigenetics in ALS-FTD spectrum: understanding the phenotypic variability and gaining new advances for personalized medicine
Centro de Investigación Biomédica de Aragón (CIBA)
Instituto de Investigación Sanitaria Aragón
SPAIN
Canarias
LAS PALMAS DE GRAN CANARIA
Understanding TDP-43 central role in ALS and other TDP43 proteinopathies
Hospital Universitario de Gran Canaria Dr. Negrín
FIISC: Fundación Canaria Instituto de Investigación Sanitaria de Canarias
SPAIN
Cataluña
BARCELONA
High resolution genotyping of the HLA genes and analysis of their expression in the CNS in Amyotrophic Lateral Sclerosis: testing the neuroinflammatory hypothesis
Hospital Universitari Vall d'Hebron
Unidad Neuromuscular
SPAIN
Cataluña
BARCELONA
Validation of candidate biomarkers for diagnosis and prognosis of Amiotrophic Lateral Esclerosis and study of pathophysiological pathways
Hospital de la Santa Creu i Sant Pau
Servicio de Neurología
SPAIN
Cataluña
BARCELONA
Advancing the classification of frontotemporal dementia and amyotrophic lateral sclerosis with microstructural and functional neuroimaging, and blood-based biomarkers of neurodegeneration and neuroinflammation
IIB Sant Pau - Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
SPAIN
Cataluña
BARCELONA
Characterization of the transcriptomic and neuropathological profile of the postmortem tissue of amyotrophic lateral sclerosis patients carrying the C9orf72 hexanucleotide repeat expansion
IIB Sant Pau - Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
SPAIN
Cataluña
LLEIDA
Cell stress, lipid metabolism and RNA processing at the crossroad of ALS pathophysiology
Instituto de Investigación Biomédica de Lleida (IRBLLEIDA)
Instituto de Investigación Biomédica de Lleida - IRBLLEIDA
SPAIN
Comunidad Valenciana
VALENCIA
Role of genetics, microbiota, and neurodegeneration and inflammation biomarkers in the development of precision medicine applied to ALS
Hospital Universitario y Politécnico La Fe
Fundación para la Investigación del Hospital Universitari La Fe
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
Epigenetics in ALS-FTD spectrum: understanding the phenotypic variability and gaining new advances for personalized medicine
Institution: Information not provided - ES
SPAIN
Madrid
MADRID
Epigenetics in ALS-FTD spectrum: understanding the phenotypic variability and gaining new advances for personalized medicine
Instituto de Investigación Hospital 12 de Octubre
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre
SPAIN
País Vasco
SAN SEBASTIÁN
The impact of cholesterol dyshomeostasis and endoplasmic-reticulum stress on mitochondrial DNA metabolism in neurological and neurodegenerative diseases
Instituto de Investigación Sanitaria Biodonostia
SPAIN
País Vasco
SAN SEBASTIÁN
Skeletal muscle stem cell regenerative function in amyotrophic lateral sclerosis: implications in the peripheral etiopathogenesis
Instituto de Investigación Sanitaria Biodonostia
SWEDEN
Region Skåne
LUND
AAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis
Lunds Universitet
Department of Experimental Medical Science
SWEDEN
Region Stockholm
STOCKHOLM
In vitro molecular mechanism of amyotrophic lateral sclerosis
Stockholm University
Department of Biochemistry and Biophysics
SWEDEN
Region Västerbotten
UMEÅ
Molecular portfolio of the extraocular muscles: clues to protection in muscular disease
Umeå Universitet
Department of Clinical Sciences
SWEDEN
Region Västerbotten
UMEÅ
Genetic factors causing sporadic and familial amyotrophic lateral sclerosis (ALS/MND) with or without dementia
Umeå Universitet
Department of Clinical Sciences
SWEDEN
Region Västerbotten
UMEÅ
Disease mechanisms in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Umeå Universitet
Department of Medical Biosciences
SWEDEN
Region Västerbotten
UMEÅ
Studies of misfolded SOD1 in amyotrophic lateral sclerosis (ALS)
Umeå Universitet
Department of Medical Biosciences
SWITZERLAND
Suisse Alémanique
ZÜRICH
Exploring the molecular basis of disease heterogeneity in TDP-43 proteinopathies
Universität Zürich
Department of Quantitative Biomedizin
SWITZERLAND
Suisse Romande
LAUSANNE
AAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis - CH
EPFL - Ecole Polytechnique Fédérale de Lausanne
Bertarelli Platform for Gene Therapy
UNITED KINGDOM
Greater London
LONDON
Investigating neuronal RNA localisation and translational deficits as gain of function mechanisms in ALS.
UCL Institute of Neurology, University College London,
Clinical Neurosciences
UNITED KINGDOM
Greater London
LONDON
Beyond the neuromuscular junction: dysfunction of spinal synaptic targets of motoneurons in Amyotrophic Lateral Sclerosis
UCL Institute of Neurology, University College London,
Clinical Neurosciences
UNITED KINGDOM
Oxfordshire
OXFORD
Antisense Oligonucleotide Therapy for Neuromuscular Disease
University of Oxford
Department of Physiology, Anatomy and Genetics
UNITED STATES
Illinois
CHICAGO
Studying nucleocytoplasmic imbalances to design new therapeutic strategies for amyotrophic lateral sclerosis
Northwestern University Feinberg School of Medicine
Department of pathology
UNITED STATES
Massachusetts
BOSTON
Misfolding of Cu/Zn superoxide dismutase by pathological FUS and TDP43: relevance to amyotrophic lateral sclerosis
Boston Children's Hospital
Division of Genetics
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Modeling the progression of sod1-linked motor neuron disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Etiological linkage of dna damage/repair deficiency in neurodegenerative diseases
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Metabolic profiling of sporadic als patients: from fibroblasts to neurons and back
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Extrinsic mechanisms governing injury-induced axon degeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Investigating disease mechanisms in c9orf72-linked als/ftd
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanisms underlying excitability regulation of motoneuron types in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
P97 inhibitors for treatment of ibmpfd/als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Muscle tregs in health and disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Ampk; metabolism and als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Epigenetic editing of mutant c9orf72
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Hexanucleotide repeat translation in als and frontotemporal dementia
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Investigating a2-chimaerin-dependent motor neuron protection in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Investigation of als caused by mutant chchd10
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of hipk2 in neurodegeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Molecular characterization of als/ftd in a novel c9orf72 bac mouse model.
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Molecular phenotyping of cortical cell types in multiple rodent models of als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
New compounds to study neurological disorders related to autophagic dysfunction
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Nucleocytoplasmic transport and nuclear pore disruption in als/ftd
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Role of c9orf72 in neurodegeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Rna decay in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Role of oligodendroglia in the pathogenesis of als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Tdp-43 proteinopathy in als-ftd: mechanism; target validation and biomarker
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Smad signaling in skeletal muscle as a biomarker of disease progression in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Study on hnrnpa1 pathobiology in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
The role of c9orf72 protein function in amyotrophic lateral sclerosis and frontotemporal dementia
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
A human stem cell-derived neuromuscular junction model for amyotrophic lateral sclerosis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
An in vivo approach to understanding mutant pfn1 toxicity on motor neurons
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Development of a microphysiological organ-on-chip system to model amyotrophic
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Determination of cell death pathways activated in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Determining the role of rna-based factors in ran translation of c9als/ftd-associated ggggcc repeats
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Delineating physiologic mechanisms of swallowing impairment and decline in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Defining the molecular basis of substrate selection by diverse hsp104 homologues
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Expanding the chemical diversity of therapeutic oligonucleotides to treat neurodegenerative disorders
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Induced pluripotent stem cells and drosophila models of c9orf72-related ftd/als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanistic studies and therapeutics for als-ftd linked to ubqln2 mutations
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mitochondrial dynamics for the maintenance of neuromuscular junctions during aging and in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Ngf and rage-p75ntr signaling in models of amyotrophic lateral sclerosis
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Oligodendroglial dysfunction in c9orf72 als and ftd
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Study on neurodegeneration using tdp-43 transgenic rats
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Using hts to identify inhibitors of r155h-p97/vcp mutant to treat ibmpfd/als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Single-molecule resolution of rna editing of mrnas: visualizing gria2 editing in situ in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Fg-nucleoporins and nuclear transport disruption in c9orf72-als/ftd
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of motor neuron disease
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Nad metabolsim and mitochondrial dysfunction in als models
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Re-establishing vascular integrity in als via endothelial cell transplant
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Regulation of glutamate transport in astrocyte subtypes and in als
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Mitochondrial inner membrane architecture in skeletal muscle pathophysiology
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Inhibiting C9ORF72 Repeat RNA Transcription with a Common Class of Small Molecules - US
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Multimeric Peptide Copolymer Formulations for Targeted Drug Delivery to Treat Nervous System Disorders
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Genetic control of phrenic motor neuron development and maintenance
Institution: Information not provided - US
FINLAND
Finland
OULU
FINCA mouse as a tool to study mechanisms behind severe fibrosis and neurodegeneration
University of Oulu
Biocenter Oulu
FRANCE
AUVERGNE-RHONE-ALPES
LYON
The extracellular matrix collagen XV as a new player of motor axon development and regeneration: a functional study using zebrafish
Institut de Génomique Fonctionnelle de Lyon
Matrix Biology and Pathology, Managemant
SPAIN
Asturias
OVIEDO
The emergent pathogenic role for the intermediate CAG repeats in the HTT gene: from the neuropathological evidences to the molecular findings
Fundación para la Investigación Biosanitaria del Principado de Asturias
FINBA: Fundación para la Investigación Biosanitaria del Principado de Asturias
SPAIN
Cataluña
BARCELONA
Advanced genomics and lipidomics for identifying novel causes of inherited movement disorders
Instituto de Química Avanzada de Cataluña
Unidad de Investigación en Moléculas Bioactivas
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Advanced genomics and lipidomics for identifying novel causes of inherited movement disorders
IDIBELL - Instituto de Investigación Biomédica de Bellvitge
Laboratorio de Enfermedades Neurometabólicas
SPAIN
País Vasco
SAN SEBASTIÁN
Advanced genomics and lipidomics for identifying novel causes of inherited movement disorders
Instituto de Investigación Sanitaria Biodonostia
Área de Neurociencias
BELGIUM
ANTWERPEN
ANTWERPEN
A preclinical study to treat neuromuscular diseases caused by mutations in the small heat shock protein HSPB8
University of Antwerp - UA, Campus Drie Eiken
Peripheral Neuropathy Research Group
CANADA
Ontario
OTTAWA, ONTARIO
Inhibition of HDAC6 as Therapeutic Strategy in Neuromuscular Diseases
University of Ottawa
Faculty of Medicine -
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Impact of pre-phonation inspiratory volume on speech quality of neuromuscular patients requiring non invasive ventilation
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Impact du type d'interface chez les patients neuromusculaires traités par ventilation non invasive nocturne: un essai croisé randomisé
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Impact of blowpipe training on cough efficiency in neuromuscular patients : a prospective evaluation.
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
L'annonce diagnostique d'une maladie neuromusculaire à l'âge adulte. Retentissements psychologiques des processus communicationnels entre médecin et patient
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
GRENOBLE
Early identification of respiratory exacerbations using NIV device monitoring in slowly progressive neuromuscular disorders
CHU Grenoble Alpes - Site Nord - Hôpital Couple Enfant
Laboratoire EFCR/Pneumologie
FRANCE
AUVERGNE-RHONE-ALPES
LYON
Interplay between cell metabolism and alternative splicing
ENS - Ecole normale supérieure de Lyon
Laboratoire de biologie et modélisation de la cellule - UMR5239
FRANCE
AUVERGNE-RHONE-ALPES
LYON
Amino acid metabolism and alternative splicing
ENS - Ecole normale supérieure de Lyon
Laboratoire de biologie et modélisation de la cellule - UMR5239
FRANCE
AUVERGNE-RHONE-ALPES
LYON
Development and validation study of a Motor Function Measure digitalized playful completion modules
Hospices Civils de Lyon
FRANCE
ILE-DE-FRANCE
CRÉTEIL
TRANSLAMUSCLE: An integrated translational program from basic research to biotherapies in stem cells and molecular medicine of the neuromuscular system
Faculté de Médecine de Créteil
Equipe "Biologie du système neuromusculaire"
FRANCE
ILE-DE-FRANCE
CRÉTEIL
An integrated translational program for neuromuscular disorders
Faculté de Médecine de Créteil
Equipe "Biologie du système neuromusculaire"
FRANCE
ILE-DE-FRANCE
CRÉTEIL
An integrated translational program for neuromuscular disorders
Hôpitaux Universitaires Henri Mondor
Centre expert de maladie neuro-musculaire
FRANCE
ILE-DE-FRANCE
GARCHES
Patient-ventilator asynchrony in neuromuscular disease: real life evaluation using devices softwares
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Physiologie-Explorations Fonctionnelles - Consultations Troubles du sommeil
FRANCE
ILE-DE-FRANCE
GARCHES
Early identification of respiratory exacerbations using NIV device monitoring in slowly progressive neuromuscular disorders
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Physiologie-Explorations Fonctionnelles - Consultations Troubles du sommeil
FRANCE
ILE-DE-FRANCE
PARIS
Nuclear genetic suppressors in yeast models of mtDNA mutations associated to neuromuscular diseases
Institut National de la Santé et de la Recherche Médicale
FRANCE
ILE-DE-FRANCE
PARIS
Neuroglobin gene overexpression: a promising tool for treating a large spectrum of neurological disorders thanks to its ability to safely and sustainably preserve mitochondrial integrity
Institut National de la Santé et de la Recherche Médicale
FRANCE
ILE-DE-FRANCE
PARIS
sPAM: Developing peptide-based drugs to target ataxin-2 in neuromuscular disease - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Traitement de la sclérose latérale amyotrophique : de la génétique au poisson zèbre"
FRANCE
PAYS DE LA LOIRE
NANTES
ExoMS: a 3D printed exoskeleton with springs to enhance upper limb mobility of children with neuromuscular disease
CHU de Nantes
CHU Nantes
FRANCE
PAYS DE LA LOIRE
NANTES
New modulators of the skeletal and cardiac ryanodine receptors
CHU de Nantes
CHU Nantes
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
Modelisation and Therapeutic Approaches for Rare Diseases
Université de médecine Aix-Marseille Université
Centre de Génétique de Marseille (Marseille Medical Genetics - MMG)
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
A quantitative MRI platform for simultaneous and automatic quantification of fat infiltration and T2 relaxation times in neuromuscular disorders - FR
Université de médecine Aix-Marseille Université
Centre de Résonance Magnétique Biologique et Médicale
ISRAEL
ISRAEL
TEL AVIV
A quantitative MRI platform for simultaneous and automatic quantification of fat infiltration and T2 relaxation times in neuromuscular disorders - IL
University of Tel-Aviv
Dep. of Bio-Medical Engineering
ITALY
LAZIO
ROMA
Diverse rare diseases caused by functional dysregulation of Rho GTPase-related proteins
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare
ITALY
LAZIO
ROMA
Cellular network driving neuromuscular junction stability
Sapienza Università di Roma
Università degli Studi di Roma "La Sapienza"
NETHERLANDS
Zuid-Holland
LEIDEN
Understanding histopathological alterations in neuromuscular disorders by spatial transcriptomics
LUMC - Leids Universitair Medisch Centrum
Afdeling Humane Genetica
NORWAY
Østlandet
OSLO
Mekanisk hostestøtte for barn med nevromuskulær sykdom og svak hoste
Oslo University Hospital, Ullevaal
Oslo University Hospital, Ullevål
SPAIN
Cataluña
BARCELONA
Igenco: In-Depth genomics and cross-omics analysis for undiagnosed rare diseases on a user-friendly collaborative platform
Centro de Regulación Genómica
Centro Nacional de Análisis Genómico
SPAIN
Cataluña
BARCELONA
Igenco: In-Depth genomics and cross-omics analysis for undiagnosed rare diseases on a user-friendly collaborative platform
ISGlobal - Instituto de Salud Global de Barcelona
Programa de investigación en Enfermedades no transmisibles y medio ambiente
UNITED KINGDOM
Tyne & Wear
NEWCASTLE UPON TYNE
Implementation of an artificial intelligence module on the web-based digital platform MyoShare for guiding the diagnosis of muscle diseases.
University of Newcastle
John Walton Muscular Dystrophy Research Centre
UNITED STATES
California
PALO ALTO
sPAM: Developing peptide-based drugs to target ataxin-2 in neuromuscular disease - US
Stanford University School of Medicine
Department of Genetics
CANADA
Colombie-Britannique
VICTORIA
Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations
University of Victoria
Community Genetics Research Program/Island Medical Program
CANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
SPAIN
Andalucía
SEVILLA
Development of bioinformatic tools for the automatic handling of secondary findings and their use in genetic and pharmacogenetic counseling
Fundación Progreso y Salud
Área de bioinformática clínica
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Centro de Regulación Genómica
Archivo europeo de genomas y fenomas del CRG
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Clínic de Barcelona
Servicio de Inmunologia
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari Vall d'Hebron
Laboratorio de Genética
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital de la Santa Creu i Sant Pau
Servicio de Genética
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Federated network for functional genomics of undiagnosed and rare diseases, RareFunction
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu
Grupo de investigación en Neurogenética y Medicina Molecular
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Sant Joan de Déu Barcelona
Servicio de Laboratorio
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari de Bellvitge
Unidad de Genética Molecular
SPAIN
Madrid
MADRID
Identification of new genes causing rare diseases in pediatric patients, searching of genetic pharmacological targets, and drugs discovery, the steps for a personalized medicine
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en enfermedades raras, mitocondriales y neuromusculares
Multicentric Research projects
- Montreal Neurological Institute and Hospital
- The Durham lab
- Faculté de Psychologie de Strasbourg
- Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA) - UMR 7364 / Université de Strasbourg / CNRS
- Faculté de médecine de Strasbourg - Louis Pasteur
- Laboratoire de signalisations moléculaires et neurodégénérescence
- Faculté de médecine de Strasbourg - Louis Pasteur
- Mécanismes centraux et périphériques de la Neurodégénérescence - INSERM U1118
- Faculté de médecine de Limoges
- Institut d'épidémiologie neurologique et de neurologie tropicale
- CHU de Montpellier - Hôpital Saint-Eloi
- Institut des Neurosciences de Montpellier - INSERM U1051
- Centre de Recherche en Cancérologie de Marseille
- Télomères et Chromatine
- Parc scientifique et technologiques de Luminy
- Trophos SA
- Klinikum rechts der Isar der Technischen Universität München
- Neurologische Klinik und Poliklinik
- Universitätsklinikum Aachen
- Klinik für Neurologie
- Administration Center for Molecular and Cellular Bioengineering c/o B CUBE
- Biotechnologisches Zentrum
- Arnold R. Meyer Institute of Biological Sciences, Weizmann Institute of Science
- Department of Molecular Genetics
- University of Tel-Aviv
- Dept. of Physiology and Pharmacology
- Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
- Dipartimento di Scienze Neurologiche
- Rudolf Magnus Institute Stratenum
- Neuromuscular Disorders Group
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neuromusculaire Ziekten
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neuromusculaire Ziekten
- UMC Utrecht - Universitair Medisch Centrum Utrecht
- Polikliniek Neuromusculaire Ziekten
- Centre Médical Universitaire - CMU
- Groupe Prof. Karl-Heinz KRAUSE
- John van Geest Centre for Brain Repair
- NeuroNE
- Institution: Information not provided - UK
- Institution: Information not provided - US
- Faculté de médecine de Clermont-Ferrand
- Laboratoire de Génétique, Reproduction et Développement
- Charité / Max-Delbrück-Centrum für Molekulare Medizin
- Muskelforschung mit Hochschulambulanz für Muskelkrankheiten
- University of Tel-Aviv
- Dep. of Bio-Medical Engineering
- Azienda Ospedaliera di Padova
- Clinica Pediatrica
- Stanford University School of Medicine
- Department of Genetics
CANADA
Québec
MONTRÉAL
RNA-ALS: Dysregulation of RNA in the pathogenesis of ALS
FRANCE
GRAND-EST
STRASBOURG
EpiFUS - Role of FUS in regulating epigenetic modifications: consequences for amyotrophic lateral sclerosis and frontotemporal dementia
FRANCE
GRAND-EST
STRASBOURG
Modulation of metabolic flexibility in Amyotrophic Lateral Sclerosis as a new therapeutic approach
FRANCE
GRAND-EST
STRASBOURG
Muscle contribution to FUS-associated ALS: genetic and mechanistic insights
FRANCE
NOUVELLE AQUITAINE
LIMOGES
EURALS: European amyotrophic lateral sclerosis consortium
FRANCE
OCCITANIE
MONTPELLIER
FaSMALS: Common Pathogenic Pathways and Therapeutics for SMA and ALS motoneuron diseases
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
REPETOMICS: Genomic Instability of Expanded Repeats in HD and ALS/FTD
FRANCE
PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
MITOTARGET: mitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics
GERMANY
Bayern
MÜNCHEN
MAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease
GERMANY
Nordrhein-Westfalen
AACHEN
Fly-SMALS: Common RNA-dependent pathways for motor neuron degeneration in spinocerebellar muscular atrophy and amyotrophic lateral sclerosis (DE)
GERMANY
Sachsen
DRESDEN
CureALS: Stress granules and proteostasis in motor neurons: towards a mechanistic understanding of ALS
ISRAEL
ISRAEL
REHOVOT
REALS: Repurposed Enoxacin for the treatment of patients with Amyotrophic Lateral Sclerosis
ISRAEL
ISRAEL
TEL AVIV
ALS-degeneration: The molecular basis for neurodegeneration and muscle atrophy in ALS
ITALY
LOMBARDIA
MILANO
INTEGRALS: INTEGRative multi-OMICs approaches on iPSC-derived 2D and 3D models to elucidate the role of immune and energy metabolism related genes/pathways in Amyotrophic Lateral Sclerosis
NETHERLANDS
Utrecht
UTRECHT
PYRAMID: Phenotype Research for ALS modifyer discovery
NETHERLANDS
Utrecht
UTRECHT
EURO-MOTOR: European multidisciplinary ALS network identification to cure motor neuron degeneration
NETHERLANDS
Utrecht
UTRECHT
Project NETCALS: Network of Cohort Assessment in ALS
NETHERLANDS
Utrecht
UTRECHT
Project SOPHIA: Sampling and biomarker OPtimization and Harmonization In ALS and other motor neuron diseases
SWITZERLAND
Suisse Romande
GENÈVE
NEURINOX: NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies
UNITED KINGDOM
Cambridgeshire
CAMBRIDGE
EUNEURONE: European Consortium for Research in Neurodegenerative Diseases
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
BRAINMEND - Biological Resource Analysis to Identify New Mechanisms and phenotypes in Neurodegenerative Diseases
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Inhibiting C9ORF72 Repeat RNA Transcription with a Common Class of Small Molecules
FRANCE
AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND
MYORES: European Muscle Development Network (FINISHED)
GERMANY
Berlin
BERLIN
EUROMUSCLENET: Europäisches Informations-Netzwerk über muskuläre Erkrankungen
ISRAEL
ISRAEL
TEL AVIV
A quantitative MRI platform for simultaneous and automatic quantification of fat infiltration and T2 relaxation times in neuromuscular disorders
ITALY
VENETO
PADOVA
Brains for brain: research group of the European task force on brain and neurodegenerative lysosomal storage diseases
UNITED STATES
California
PALO ALTO